REGN910-3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN910-3, covering 2016-01-12 to 2016-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) [Phase 1]